BioMarin Pharmaceutical stock price
바이오마린 파머슈티컬NASDAQ:BMRN · Nasdaq · Healthcare$57.18-2.16%
2026-10-02 closeLoading chart…
Today's signals · No active technical signal.
Signal details →BioMarin Pharmaceutical last closed at $57.18 (-2.16%) on 2026-10-02. Listed on Nasdaq. Trailing 12 months PER is 152.1×. Its overall grade ranks 454 of 739 stocks in Healthcare.
About this company
BioMarin Pharmaceutical last closed at $57.18 (-2.16%) on 2026-10-02. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall C+ · 454/739
Valuation grade F
Related stocks
- RocheCompetitor
희귀질환·효소대체요법 등에서 경쟁
- SanofiCompetitor
희귀질환/유전자·바이오의약 경쟁
- Takeda PharmaceuticalCompetitor
희귀질환 치료제 경쟁
ETFs holding this stock
Global X Genomics And Biotechnology ETF
Details →About BioMarin Pharmaceutical
- What technical signals does BioMarin Pharmaceutical (BMRN) have?
- BioMarin Pharmaceutical current technical signals: no active technical signal.
- Is BioMarin Pharmaceutical a cup-and-handle pattern?
- No. BioMarin Pharmaceutical has no valid Cup signal right now.
- What published figures are available for BioMarin Pharmaceutical?
- Market cap: $10.99B. Trailing 12 months PER: 152.1×. Latest quarter PBR: 1.76×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-04 dataset
Turn what you saw on this name into a strategy
Ask Q about BioMarin Pharmaceutical, or open the plan table on the main site.
From the names you found, through to a scheduled run
Set the conditions and they run at the scheduled time (live orders are not open yet).
Quantus Signal · live data · not investment advice · Privacy Policy